Tissue n - 3 and n - 6 fatty acids and risk for coronary heart disease events

William Harris, W. Carlos Poston, C. Keith Haddock

Research output: Contribution to journalArticle

200 Citations (Scopus)

Abstract

Background: Tissue proportions of long chain n - 6 [especially arachidonic acid (AA)] and n - 3 fatty acids [FA; eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) acids], or some ratio of these may be markers of risk for coronary heart disease (CHD). The purpose of this paper is to evaluate the published associations between risk for CHD events and tissue n - 3 and n - 6 FA composition. Methods: Case-control or prospective cohort data sets examining the risk for CHD endpoints as a function of tissue FA composition were identified. Effect sizes were computed for case versus control comparisons using standard meta-analytic methods. Results: Twenty-five studies were included, 18 examining the FA composition of phospholipid-rich and 7 of triglyceride-rich samples. DHA, with or without EPA, was significantly lower in cases than controls in all studies combined, in those with fatal endpoints, in those with prospective designs, and in both tissue types. The only setting where increased AA was associated with case status was in adipose tissue. The AA/EPA ratio in phospholipid-rich samples did not distinguish cases from controls. Lower linoleic acid content was associated with increased risk for non-fatal events. Conclusions: The long-chain n - 3 FA, especially DHA, were consistently and significantly reduced in patients experiencing CHD events. These findings add further support to the view that long-chain n - 3 FA are cardioprotective.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalAtherosclerosis
Volume193
Issue number1
DOIs
StatePublished - Jul 2007
Externally publishedYes

Fingerprint

Eicosapentaenoic Acid
Coronary Disease
Docosahexaenoic Acids
Fatty Acids
Arachidonic Acid
Phospholipids
Omega-3 Fatty Acids
Linoleic Acid
Adipose Tissue
Triglycerides
Acids

Keywords

  • Coronary disease
  • Fatty acids
  • Fish oil
  • Myocardial infarction
  • Sudden cardiac death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Tissue n - 3 and n - 6 fatty acids and risk for coronary heart disease events. / Harris, William; Poston, W. Carlos; Haddock, C. Keith.

In: Atherosclerosis, Vol. 193, No. 1, 07.2007, p. 1-10.

Research output: Contribution to journalArticle

Harris, William ; Poston, W. Carlos ; Haddock, C. Keith. / Tissue n - 3 and n - 6 fatty acids and risk for coronary heart disease events. In: Atherosclerosis. 2007 ; Vol. 193, No. 1. pp. 1-10.
@article{5d1586b884b3412385048f98fad4c2c5,
title = "Tissue n - 3 and n - 6 fatty acids and risk for coronary heart disease events",
abstract = "Background: Tissue proportions of long chain n - 6 [especially arachidonic acid (AA)] and n - 3 fatty acids [FA; eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) acids], or some ratio of these may be markers of risk for coronary heart disease (CHD). The purpose of this paper is to evaluate the published associations between risk for CHD events and tissue n - 3 and n - 6 FA composition. Methods: Case-control or prospective cohort data sets examining the risk for CHD endpoints as a function of tissue FA composition were identified. Effect sizes were computed for case versus control comparisons using standard meta-analytic methods. Results: Twenty-five studies were included, 18 examining the FA composition of phospholipid-rich and 7 of triglyceride-rich samples. DHA, with or without EPA, was significantly lower in cases than controls in all studies combined, in those with fatal endpoints, in those with prospective designs, and in both tissue types. The only setting where increased AA was associated with case status was in adipose tissue. The AA/EPA ratio in phospholipid-rich samples did not distinguish cases from controls. Lower linoleic acid content was associated with increased risk for non-fatal events. Conclusions: The long-chain n - 3 FA, especially DHA, were consistently and significantly reduced in patients experiencing CHD events. These findings add further support to the view that long-chain n - 3 FA are cardioprotective.",
keywords = "Coronary disease, Fatty acids, Fish oil, Myocardial infarction, Sudden cardiac death",
author = "William Harris and Poston, {W. Carlos} and Haddock, {C. Keith}",
year = "2007",
month = "7",
doi = "10.1016/j.atherosclerosis.2007.03.018",
language = "English (US)",
volume = "193",
pages = "1--10",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Tissue n - 3 and n - 6 fatty acids and risk for coronary heart disease events

AU - Harris, William

AU - Poston, W. Carlos

AU - Haddock, C. Keith

PY - 2007/7

Y1 - 2007/7

N2 - Background: Tissue proportions of long chain n - 6 [especially arachidonic acid (AA)] and n - 3 fatty acids [FA; eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) acids], or some ratio of these may be markers of risk for coronary heart disease (CHD). The purpose of this paper is to evaluate the published associations between risk for CHD events and tissue n - 3 and n - 6 FA composition. Methods: Case-control or prospective cohort data sets examining the risk for CHD endpoints as a function of tissue FA composition were identified. Effect sizes were computed for case versus control comparisons using standard meta-analytic methods. Results: Twenty-five studies were included, 18 examining the FA composition of phospholipid-rich and 7 of triglyceride-rich samples. DHA, with or without EPA, was significantly lower in cases than controls in all studies combined, in those with fatal endpoints, in those with prospective designs, and in both tissue types. The only setting where increased AA was associated with case status was in adipose tissue. The AA/EPA ratio in phospholipid-rich samples did not distinguish cases from controls. Lower linoleic acid content was associated with increased risk for non-fatal events. Conclusions: The long-chain n - 3 FA, especially DHA, were consistently and significantly reduced in patients experiencing CHD events. These findings add further support to the view that long-chain n - 3 FA are cardioprotective.

AB - Background: Tissue proportions of long chain n - 6 [especially arachidonic acid (AA)] and n - 3 fatty acids [FA; eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) acids], or some ratio of these may be markers of risk for coronary heart disease (CHD). The purpose of this paper is to evaluate the published associations between risk for CHD events and tissue n - 3 and n - 6 FA composition. Methods: Case-control or prospective cohort data sets examining the risk for CHD endpoints as a function of tissue FA composition were identified. Effect sizes were computed for case versus control comparisons using standard meta-analytic methods. Results: Twenty-five studies were included, 18 examining the FA composition of phospholipid-rich and 7 of triglyceride-rich samples. DHA, with or without EPA, was significantly lower in cases than controls in all studies combined, in those with fatal endpoints, in those with prospective designs, and in both tissue types. The only setting where increased AA was associated with case status was in adipose tissue. The AA/EPA ratio in phospholipid-rich samples did not distinguish cases from controls. Lower linoleic acid content was associated with increased risk for non-fatal events. Conclusions: The long-chain n - 3 FA, especially DHA, were consistently and significantly reduced in patients experiencing CHD events. These findings add further support to the view that long-chain n - 3 FA are cardioprotective.

KW - Coronary disease

KW - Fatty acids

KW - Fish oil

KW - Myocardial infarction

KW - Sudden cardiac death

UR - http://www.scopus.com/inward/record.url?scp=34248679878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248679878&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2007.03.018

DO - 10.1016/j.atherosclerosis.2007.03.018

M3 - Article

C2 - 17507020

AN - SCOPUS:34248679878

VL - 193

SP - 1

EP - 10

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 1

ER -